XT
ALXO icon

XTX Topco’s ALX Oncology ALXO Stock Holding History

XTX Topco’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88.5K Buy
+44,141
New +$84.1K ﹤0.01% 3141
2025
Q4 		– Sell
-26,621
Closed -$48.7K – 3282
2025
Q3 		$48.7K Sell
26,621
-48,149
-64% -$41.7K ﹤0.01% 2177
2025
Q2 		$31K Sell
74,770
-17,489
-19% -$8.83K ﹤0.01% 2102
2025
Q1 		$57.5K Sell
92,259
-171,597
-65% -$206K ﹤0.01% 1980
2024
Q4 		$441K Sell
263,856
-53,466
-17% -$82.2K 0.04% 882
2024
Q3 		$578K Buy
+317,322
New +$1.18M 0.04% 720
2024
Q2 		– Sell
-10,911
Closed -$122K – 1825
2024
Q1 		$122K Buy
+10,911
New +$153K 0.02% 1322
2023
Q4 		– Sell
-10,740
Closed -$51.6K – 1546
2023
Q3 		$51.6K Buy
+10,740
New +$58.3K 0.01% 1274
2023
Q2 		– Sell
-25,817
Closed -$117K – 1381
2023
Q1 		$117K Buy
+25,817
New +$196K 0.02% 1067

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

XTX Topco's ALXO Position: Q1 2026 in Review

XTX Topco opened a new position in ALX Oncology (ALXO) in Q1 2026: 44,141 shares worth $88.5K. The stake represents ﹤0.01% of the portfolio and ranks #3141 among its holdings. This is a return to the name: XTX Topco previously reported a position in ALXO as recently as Q3 2025.

XTX Topco first reported a position in ALXO in Q1 2023 and has held it in 9 quarters since. The position peaked at $578K in Q3 2024. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • XTX Topco held 44,141 shares of ALX Oncology worth $88.5K as of Q1 2026.
  • ALX Oncology was a new XTX Topco position in Q1 2026.
  • ALX Oncology made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3141 holding.
  • XTX Topco first reported a position in ALX Oncology in Q1 2023 and has held it in 9 quarters since.
  • XTX Topco's ALX Oncology position peaked at $578K in Q3 2024.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.